Transcriptome analysis of ankylosing spondylitis patients before and after TNF-α inhibitor therapy reveals the pathways affected.

about

Transcriptome analysis of ankylosing spondylitis patients before and after TNF-α inhibitor therapy reveals the pathways affected.

Item

http://www.wikidata.org/entity/Q40081875

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Transcriptome analysis of anky ...... reveals the pathways affected.

@en

type

Item

label

Transcriptome analysis of anky ...... reveals the pathways affected.

@en

prefLabel

Transcriptome analysis of anky ...... reveals the pathways affected.

@en

P1476

Transcriptome analysis of anky ...... reveals the pathways affected

@en

P2093

D J Pennisi

http://www.w3.org/2001/XMLSchema#string

J Batra

http://www.w3.org/2001/XMLSchema#string

J J Ellis

http://www.w3.org/2001/XMLSchema#string

K Hollis

http://www.w3.org/2001/XMLSchema#string

L A Bradbury

http://www.w3.org/2001/XMLSchema#string

X B Wang

http://www.w3.org/2001/XMLSchema#string

X Song

http://www.w3.org/2001/XMLSchema#string

Z Li

http://www.w3.org/2001/XMLSchema#string

P2860

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

Use of RNA sequencing to evaluate rheumatic disease patients

Interleukin-17 and type 17 helper T cells

Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

STRING v9.1: protein-protein interaction networks, with increased coverage and integration

STAR: ultrafast universal RNA-seq aligner

Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci

Long-term efficiency of infliximab in patients with ankylosing spondylitis: real life data confirm the potential for dose reduction

P2888

gene.2017.19

P304

184-190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GENE.2017.19

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tony J. Kenna

Matthew A. Brown

P577

2017-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28835680

http://www.w3.org/2001/XMLSchema#string